Proteins and Peptides

05 Oct 2007 ThromboGenics and Rhein Minapharm Announce Agreement
04 Oct 2007 Peptimmune Initiates Phase I Study With a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
04 Oct 2007 Roche and Trimeris Provide Update on Development of Alternative Administration Options for Delivery of FUZEON(R)
04 Oct 2007 MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
04 Oct 2007 Protox completes BPH trial recruitment and announces positive interim data
03 Oct 2007 Chemokine Therapeutics Completes Patient Recruitment of CTCE-9908 Phase I/II Clinical Trial
03 Oct 2007 CardioVascular BioTherapeutics Completes Phase I Wound Healing Trial
02 Oct 2007 FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
02 Oct 2007 BioLineRx In-Licenses Novel Peptide BL-4050 for the Treatment of Cancer
02 Oct 2007 Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity
28 Sep 2007 Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
28 Sep 2007 Nuvelo Announces Publication of NU206 Study Results in Proceedings of the National Academy of Sciences of the United States of America
28 Sep 2007 Palatin Technologies, Inc. Reports positive data from an at-home study of pre- and postmenopausal women with female sexual arousal disorder treated with bremelanotide
27 Sep 2007 Nycomed and NPS Pharmaceuticals Announce Licensing Agreement for GATTEX(TM)
27 Sep 2007 Phase 2 Study Suggests That Extended Dosing of Aranesp(R) is as Efficacious as Weekly Dosing
27 Sep 2007 Affibody to Start Clinical Development of a New Approach for the Diagnosis of Cancer
27 Sep 2007 Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
27 Sep 2007 Cytheris Expands Interleukin-7 Clinical Development Program With International Phase I/IIa Trial In HIV
27 Sep 2007 New Analysis Suggests First Cycle Use of Neulasta(R) Reduces Febrile Neutropenia Hospitalizations and Chemotherapy Dose Reductions in Breast Cancer Patients Compared to Current Practice
27 Sep 2007 OctoPlus in-licenses diabetes product candidate
25 Sep 2007 Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
25 Sep 2007 European Union's CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
25 Sep 2007 Pacgen Announces Advances in PAC-113 Program
22 Sep 2007 ThromboGenics Completes Enrolment of Patients for the Vitreomacular Traction Trial (MIVI IIT)
22 Sep 2007 Maxygen Announces Hold on MAXY-alpha Development Program

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up